CollPlant Moves into Photonics
CollPlant Biotechnologies has reached a definitive agreement to acquire LightSolver. This Israeli deep-tech firm creates computing architecture based on light. The deal marks a pivot for the Nasdaq-listed company as it adds high-performance supercomputing to its portfolio. The acquisition is expected to close this week.
LightSolver specializes in pure photonic computing. The company developed the Laser Processing Unit or LPU. This platform uses the physical interaction of lasers to perform calculations. By moving away from traditional electronic transistors, the LPU handles large-scale data tasks with high speed and low energy usage. It runs at room temperature. This removes the need for cryogenic cooling systems common in other high-end computing models.
The Technical Edge of LPU Technology
Computers usually process data by moving bits between memory and a processor. The LPU takes a different approach. It maps mathematical problems directly onto an optical system. Large numbers of variables interact simultaneously in this medium. The result is a platform that performs massive parallel computation.
This technology acts as a new layer alongside existing hardware. Engineers intend for the LPU to sit next to CPUs and GPUs. It targets complex workloads including partial differential equations and linear systems. These fields drive Physical AI, robotics, and plasma physics. LightSolver aims for full commercial availability of the LPU by 2028.
Validation Through Industry Partnerships
LightSolver has secured real-world validation with several major global players. Boeing entered a strategic partnership focused on aerospace simulations. The project aims to accelerate physics-based modeling for maintenance and structural analysis. Simulations that previously took days may soon complete in milliseconds.
Other partners include firms in the energy and defense sectors. These companies use the LPU to solve optimization problems. Software engineering firms are also testing the platform for mechanical design and fluid dynamics. These collaborations suggest that the technology is ready for mission-critical use cases across varied industries.
Structure and Future of the Combined Firm
CollPlant plans to keep its focus on regenerative medicine and medical aesthetics. Yehiel Tal, the CEO of CollPlant, described the acquisition as a growth vector. He noted that the company remains dedicated to its existing healthcare initiatives. The move provides a new path for capital allocation.
Transaction terms involve an equity-centric approach. CollPlant will issue over 3.7 million shares as an upfront payment. Further compensation includes pre-funded warrants and milestone-based warrants. These depend on the future success of LightSolver technology. Shareholders must approve parts of this issuance to ensure compliance with Nasdaq rules. H.C. Wainwright & Co. and Rodman & Renshaw served as financial advisors for the deal.